In the 131I-Cat-CpG/ALG treatment group, more effector memory T cells (TEM), and higher serum levels of TNF-α and IFN-γ were observed following tumor rechallenging, indicating long-term protection of immunological memory induced by 131I-Cat-CpG/ALG 89. This evidence concerns the gene IFNG and neoplasm.